Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.

RAS brain tumor neurofibromatosis type 1 neurofibromin optic nerve optic pathway glioma retinal ganglion cell vision loss

Journal

Journal of neuroscience research
ISSN: 1097-4547
Titre abrégé: J Neurosci Res
Pays: United States
ID NLM: 7600111

Informations de publication

Date de publication:
01 2019
Historique:
received: 12 03 2018
accepted: 09 04 2018
pubmed: 29 4 2018
medline: 12 6 2020
entrez: 29 4 2018
Statut: ppublish

Résumé

Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome caused by mutations in the NF1 gene. The NF1-encoded protein (neurofibromin) is an inhibitor of the oncoprotein RAS and controls cell growth and survival. Individuals with NF1 are prone to developing low-grade tumors of the optic nerves, chiasm, tracts, and radiations, termed optic pathway gliomas (OPGs), which can cause vision loss. A paucity of surgical tumor specimens and of patient-derived xenografts for investigative studies has limited our understanding of human NF1-associated OPG (NF1-OPG). However, mice genetically engineered to harbor Nf1 gene mutations develop optic gliomas that share many features of their human counterparts. These genetically engineered mouse (GEM) strains have provided important insights into the cellular and molecular determinants that underlie mouse Nf1 optic glioma development, maintenance, and associated vision loss, with relevance by extension to human NF1-OPG disease. Herein, we review our current understanding of NF1-OPG pathobiology and describe the mechanisms responsible for tumor initiation, growth, and associated vision loss in Nf1 GEM models. We also discuss how Nf1 GEM and other preclinical models can be deployed to identify and evaluate molecularly targeted therapies for OPG, particularly as they pertain to future strategies aimed at preventing or improving tumor-associated vision loss in children with NF1.

Identifiants

pubmed: 29704429
doi: 10.1002/jnr.24250
pmc: PMC6766750
mid: NIHMS1051233
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-56

Subventions

Organisme : NCI NIH HHS
ID : R01 CA195692
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS097211
Pays : United States

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Références

Hum Mol Genet. 2007 May 1;16(9):1098-112
pubmed: 17400655
Invest Ophthalmol Vis Sci. 2014 Mar 10;55(3):1402-8
pubmed: 24519429
Nat Genet. 1994 Jul;7(3):353-61
pubmed: 7920653
J Clin Invest. 2008 May;118(5):1739-49
pubmed: 18398503
Am J Med Genet A. 2010 Feb;152A(2):327-32
pubmed: 20082463
Neuro Oncol. 2012 Jun;14(6):790-7
pubmed: 22474213
Neurology. 2018 Feb 20;90(8):377-379
pubmed: 29367450
Neurology. 2004 Nov 23;63(10):1944-6
pubmed: 15557519
Cancer Res. 2008 Nov 1;68(21):8673-7
pubmed: 18974108
J Neurooncol. 2003 Sep;64(3):203-9
pubmed: 14558595
Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2401-5
pubmed: 12091443
Neuro Oncol. 2017 Aug 1;19(8):1135-1144
pubmed: 28339824
J Neuropathol Exp Neurol. 2010 Oct;69(10):1017-1033
pubmed: 20838243
EMBO J. 2010 Jan 6;29(1):222-35
pubmed: 19927122
Am J Ophthalmol. 2004 Mar;137(3):407-14
pubmed: 15013861
Neurol Genet. 2017 Jul 26;3(4):e169
pubmed: 28804759
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13469-74
pubmed: 19805021
Cell. 2012 Apr 13;149(2):274-93
pubmed: 22500797
Brain. 2003 Jan;126(Pt 1):152-60
pubmed: 12477702
Cancer. 2015 Dec 1;121(23):4190-6
pubmed: 26280460
J Neurosurg. 1988 Jan;68(1):85-98
pubmed: 3275755
J Histochem Cytochem. 2017 Oct;65(10):607-618
pubmed: 28846462
Cancer Cell. 2012 Jul 10;22(1):131-8
pubmed: 22789544
J Neurosurg. 1979 Mar;50(3):305-11
pubmed: 422981
Ann Neurol. 2014 Feb;75(2):309-16
pubmed: 24375753
J Clin Oncol. 1993 May;11(5):850-6
pubmed: 8487049
Cancer Res. 2007 Sep 15;67(18):8588-95
pubmed: 17875698
Lancet. 2003 Jun 14;361(9374):2059-67
pubmed: 12814730
Med Hypotheses. 2006;67(2):251-69
pubmed: 16513287
J Clin Oncol. 2006 Jun 1;24(16):2570-5
pubmed: 16735710
Nature. 1992 Apr 23;356(6371):713-5
pubmed: 1570015
Genes Dev. 1994 May 1;8(9):1019-29
pubmed: 7926784
Br J Ophthalmol. 2001 Apr;85(4):420-3
pubmed: 11264130
J Pediatr. 1989 May;114(5):788-92
pubmed: 2497236
Neuro Oncol. 2013 Mar;15(3):391-400
pubmed: 23295772
Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8573-8
pubmed: 15937108
Cancer Res. 2008 Dec 15;68(24):10358-66
pubmed: 19074905
J Pathol. 2009 Jun;218(2):172-81
pubmed: 19373855
J Exp Med. 2017 Jan;214(1):17-25
pubmed: 27923908
Ann Neurol. 2014 May;75(5):799-800
pubmed: 24740685
Hum Mol Genet. 2016 May 1;25(9):1703-13
pubmed: 26908603
Hum Genomics. 2011 Oct;5(6):623-90
pubmed: 22155606
Neuro Oncol. 2015 Jun;17(6):843-53
pubmed: 25534823
J Neuropathol Exp Neurol. 2001 Sep;60(9):917-20
pubmed: 11556548
Hum Mol Genet. 2006 Mar 15;15(6):1015-23
pubmed: 16461335
Nature. 2017 Aug 3;548(7665):103-107
pubmed: 28746305
Am J Ophthalmol. 2001 Apr;131(4):442-5
pubmed: 11292406
Cell Stem Cell. 2012 Jun 14;10(6):698-708
pubmed: 22704510
Cancer Res. 2005 Apr 1;65(7):2755-60
pubmed: 15805275
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93
pubmed: 17971532
J Neuropathol Exp Neurol. 2009 May;68(5):542-51
pubmed: 19525901
J Neurosci. 2012 Oct 10;32(41):14087-93
pubmed: 23055477
Trans Am Ophthalmol Soc. 2009 Dec;107:161-5
pubmed: 20126492
Cell. 1990 Jul 13;62(1):187-92
pubmed: 1694727
Am J Med Genet. 1999 Mar 26;89(1):1-6
pubmed: 10469430
Cancer Cell. 2008 Aug 12;14(2):135-45
pubmed: 18691548
Nature. 2009 Jan 29;457(7229):603-7
pubmed: 19092805
Transl Oncol. 2008 Dec;1(4):158-64
pubmed: 19043526
J Neurosci. 2010 Apr 21;30(16):5579-89
pubmed: 20410111
Hum Mol Genet. 2014 Dec 20;23(25):6712-21
pubmed: 25070947
Gene Ther. 2005 Feb;12(4):289-98
pubmed: 15616607
Eur J Hum Genet. 2015 Aug;23(8):1068-71
pubmed: 25370043
Neuron. 1997 Aug;19(2):283-92
pubmed: 9292719
Drugs. 2003;63(15):1549-63
pubmed: 12887262
Arch Ophthalmol. 1980 Mar;98(3):505-11
pubmed: 6767467
Cancer Cell. 2008 Aug 12;14(2):123-34
pubmed: 18691547
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9914-8
pubmed: 1946460
Genes Dev. 2010 Oct 15;24(20):2317-29
pubmed: 20876733
PLoS One. 2014 Dec 23;9(12):e115579
pubmed: 25536045
Brain. 2016 Feb;139(Pt 2):404-14
pubmed: 26767384
Ann Neurol. 2013 Feb;73(2):303-8
pubmed: 23424002
Cancer Cell. 2002 Dec;2(6):507-14
pubmed: 12498719
Cell Stem Cell. 2007 Oct 11;1(4):443-57
pubmed: 18371380
Am J Ophthalmol. 2015 Nov;160(5):944-952.e1
pubmed: 26231306
Small GTPases. 2010 Jul;1(1):2-27
pubmed: 21686117
Oncotarget. 2017 Jul 18;8(29):47206-47215
pubmed: 28525381
Genes Dev. 2001 Apr 1;15(7):859-76
pubmed: 11297510
J Clin Invest. 2016 Aug 1;126(8):3104-16
pubmed: 27427986
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
pubmed: 5279523
J Neuropathol Exp Neurol. 2011 Jul;70(7):622-33
pubmed: 21666496
Cell. 1990 Jul 13;62(1):193-201
pubmed: 2114220
J Neurosurg. 1997 May;86(5):747-54
pubmed: 9126887
Curr Opin Genet Dev. 2003 Feb;13(1):20-7
pubmed: 12573431
Neuropathol Appl Neurobiol. 2000 Aug;26(4):361-7
pubmed: 10931370
Acta Neuropathol. 1987;74(3):269-77
pubmed: 3314311
J Neuropathol Exp Neurol. 2011 Jan;70(1):51-62
pubmed: 21157378
Cell. 1990 Aug 10;62(3):599-608
pubmed: 2116237
Cell. 1990 Nov 16;63(4):835-41
pubmed: 2121369
Cell. 1990 Nov 16;63(4):851-9
pubmed: 2121371
Arch Ophthalmol. 2006 Mar;124(3):379-85
pubmed: 16534058
Am J Ophthalmol. 2011 Mar;151(3):542-9.e2
pubmed: 21232732
Pediatr Blood Cancer. 2011 Sep;57(3):481-5
pubmed: 21241008
J Pediatr. 1994 Jul;125(1):63-6
pubmed: 8021787
Gene Ther. 2012 Feb;19(2):127-36
pubmed: 21975466
Cancer Res. 2012 Jul 1;72(13):3350-9
pubmed: 22573716
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83
pubmed: 14645703
Genes Cancer. 2011 Mar;2(3):344-58
pubmed: 21779504
Neurorehabil Neural Repair. 2011 May;25(4):386-90
pubmed: 21343523
Development. 2005 Dec;132(24):5577-88
pubmed: 16314489
Cell. 2007 Jun 1;129(5):865-77
pubmed: 17540168
Science. 1990 Jul 13;249(4965):181-6
pubmed: 2134734
Cell. 2017 Jun 29;170(1):17-33
pubmed: 28666118
Am J Hum Genet. 2018 Jan 4;102(1):69-87
pubmed: 29290338
J Neuropathol Exp Neurol. 2000 Sep;59(9):759-67
pubmed: 11005256
J Pediatr. 2015 Oct;167(4):851-856.e1
pubmed: 26233602
Hum Genet. 1979 Nov 1;52(1):1-54
pubmed: 393614
Front Cell Neurosci. 2014 May 13;8:129
pubmed: 24860431
Pediatr Blood Cancer. 2013 Jan;60(1):71-6
pubmed: 22434731
Ann Neurol. 2014 May;75(5):800-1
pubmed: 24752946
J Med Genet. 1989 Nov;26(11):704-11
pubmed: 2511318
Eur J Cancer. 2010 Aug;46(12):2253-9
pubmed: 20400294
Hum Mol Genet. 2015 Jun 15;24(12):3518-28
pubmed: 25788518
Neoplasia. 2015 Oct;17(10):776-88
pubmed: 26585233
Cancer Res. 2003 Dec 15;63(24):8573-7
pubmed: 14695164
Am J Hum Genet. 2007 Jan;80(1):140-51
pubmed: 17160901
Neuro Oncol. 2017 Jun 1;19(6):808-819
pubmed: 28039362
Cell. 2015 May 7;161(4):803-16
pubmed: 25913192
J Neurosci. 2005 Jun 8;25(23):5584-94
pubmed: 15944386
Nat Neurosci. 2016 Jan;19(1):20-7
pubmed: 26713745
J Biol Chem. 2000 Jun 30;275(26):20020-6
pubmed: 10777492
Genome Res. 2013 Mar;23(3):431-9
pubmed: 23222849
Cancer Res. 2008 Mar 1;68(5):1520-8
pubmed: 18316617
Cell Rep. 2015 Mar 24;10(11):1899-912
pubmed: 25772366
J Neurosci. 2006 Jul 19;26(29):7619-28
pubmed: 16855089
J Med Genet. 2011 Apr;48(4):256-60
pubmed: 21278392
Semin Cancer Biol. 2019 Feb;54:14-28
pubmed: 29175106
Front Oncol. 2017 Oct 30;7:251
pubmed: 29164051
Nature. 1991 Jun 13;351(6327):576-9
pubmed: 1904555
Exp Eye Res. 2005 Nov;81(5):561-9
pubmed: 15949799
Nat Genet. 1996 Feb;12(2):144-8
pubmed: 8563751
Cancer Res. 2010 Jul 15;70(14):5717-27
pubmed: 20551058
Nat Commun. 2015 Jun 11;6:7391
pubmed: 26067104
Neuro Oncol. 2000 Oct;2(4):213-20
pubmed: 11265230
Neurology. 2003 Nov 25;61(10):1397-400
pubmed: 14638962
Nat Commun. 2016 Feb 04;7:10472
pubmed: 26843334
Neuro Oncol. 2007 Oct;9(4):430-7
pubmed: 17704361
Neuroscience. 2010 Sep 29;170(1):178-88
pubmed: 20600672
J Med Genet. 2006 Apr;43(4):289-94
pubmed: 16155191
Ann Neurol. 2007 Mar;61(3):189-98
pubmed: 17387725
Hum Pathol. 1982 Mar;13(3):226-35
pubmed: 6281164
Cancer Res. 2009 Sep 15;69(18):7393-401
pubmed: 19738042
J Neurooncol. 2011 Sep;104(2):423-38
pubmed: 21193945

Auteurs

Morgan E Freret (ME)

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri.

David H Gutmann (DH)

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH